Ireland Prepares New Biosimilar Policy To Improve Access, Boost Industry

Ireland is developing a new policy intended to increase the use of biosimilars, taking account of initiatives in other countries. The government says the aim is to help boost competition and access to cheaper biologicals.

Medicines and money
Ireland hopes wider use of biosimilars will help rein in healthcare costs

More from Biosimilars

More from Biosimilars & Generics